The Annual ISPE Boston Product Show is the premier one-day biopharmaceutical show in the Northeast and the flagship event of the ISPE Boston Area Chapter.

The Annual ISPE Boston Product Show is the premier one-day biopharmaceutical show in the Northeast and the flagship event of the ISPE Boston Area Chapter.
Olympus announced today the results of a pilot study showing the safety and effectiveness of the ViziShot 2 FLEX 19 G EBUS-TBNA Needle in gathering tissue samples critical to guiding treatment of non-small cell lung cancer (NSCLC).
Boston Scientific completes the acquisition of the global surgical business of Lumenis LTD., a privately-held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA).
Boise State researchers believe graphene foam-enhanced cartilage could one day be used to treat the joint pain caused by osteoarthritis as well as prevent the need for joint replacement. Osteoarthritis is incurable and affects half the U.S. population over the age of 65.
More than a century after its discovery, no effective prevention or treatment exists for this progressive deterioration of brain tissue, memory and identity. With more people living to older ages, there is a growing need to clarify Alzheimer’s disease risk factors and disease mechanisms and use this information to find new ways in which to treat and prevent this terrible disorder.
Thousands of people do not know they have Parkinson’s disease. Eric Horvitz wants them to be able to find out — before the incurable neurodegenerative disorder progresses to its later stages. In his perfect world, they wouldn’t have to interrupt their daily routines. They could stay in their homes and offices, working on their computers, and their online activity would eventually trigger a message: A visit to the doctor is in order.
A study recently published in the journal Magnetic Resonance in Medicine and co-authored by Stanford life-science research assistant Itamar Terem, then-postdoc Samantha Jane Holdsworth, PhD, (now at the University of Auckland) and several other Stanford colleagues describes a new imaging method that, by means of a kind of strobe-action amplification technique, is able to visually blow up the minute heartbeat-induced pulsations of the brain to produce mind-boggling video sequences such as the one you’ve hopefully taken a peek at here.
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.
ACROMEC Limited (“ACROMEC”, SGX:43F), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, has secured three new contracts totaling approximately S6.2 million.
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has agreed to acquire Juniper Pharmaceuticals, Inc. (NASDAQ: JNPR), including its Nottingham, U.K.-based Juniper Pharma Services division.
Russian researchers from the Moscow Institute of Physics and Technology have developed biosensor chips of unprecedented sensitivity, which are based on copper instead of the conventionally used gold. Besides making the device somewhat cheaper, this innovation will facilitate the manufacturing process.
Bayer Strategic Partnership formed. Bayer and the Broad Institute of MIT and Harvard announced the launch of the joint Precision Cardiology Laboratory, which will pursue novel scientific insights to enable the development of new therapies for patients with cardiovascular diseases such as heart failure.